priors.science/reviews/ace-inhibitors-and-angiotensin-receptor-blockers

ACE Inhibitors and Angiotensin Receptor Blockers

The current evidence on 18 claims, ordered from most established to most contested. Each score is the panel’s evidence certainty — how firmly the literature supports the claim as stated.

18claims tracked
153primary papers reviewed
9 Aug 2026latest evidence review
Weeklyre-scored against new papers
7 Established · 6 Likely · 4 Uncertain · 1 Doubtful  |  four-reviewer panel · PICO Framework
ClaimStandingEvidence certaintyCorpus
ACE inhibitors and ARBs slow proteinuric chronic kidney diseaseRenalEstablished92%11
ACE inhibitors and ARBs reduce diabetic nephropathyRenalEstablished92%16
ACE inhibitors and ARBs reduce mortality in heart failure with reduced ejection fractionHfrefEstablished91%20
ACE inhibitor angioedema higher in Black patientsSafetyEstablished88%10
Dual blockade increases hyperkalemiaDualEstablished87%8
ACE inhibitor-induced cough is frequentSafetyEstablished87%13
ARBs have lower adverse drug reaction risk than ACE inhibitorsSafetyEstablished86%11
ACE inhibitors and ARBs: similar cardiovascular protectionComparativeLikely78%14
ACE inhibitors and ARBs reduce major adverse cardiovascular events in high cardiovascular riskCVLikely78%15
ACE inhibitor and ARB withdrawal worsens heart failure outcomesHfrefLikely77%9
Hyperkalemia limits ACE inhibitor and ARB use in chronic kidney diseaseRenalLikely77%20
Combined ACE inhibitor and ARB: no cardiovascular benefitDualLong-standingLikely75%8
No renal benefit from stopping ACE inhibitors and ARBsRenalLikely71%13
ACE inhibitors and ARBs improve ejection fraction in dilated cardiomyopathyHfrefUncertain69%9
ACE inhibitors: worse cardiovascular outcomes in Black patientsCVUncertain66%9
Women benefit from lower ACE inhibitor and ARB dosesHfrefUncertain63%10
ARBs versus ACE inhibitors: lower all-cause mortalityComparativeUncertain59%15
ACE inhibitor angioedema onset is delayedSafetyDoubtful39%7
Track ACE Inhibitors and Angiotensin Receptor Blockers.
These claims are re-scored against new papers every week. Track this topic for the full review, including each claim’s challenge and the papers behind it.
Track this topic →
Standing — what the evidence certainty means
Established≥ 85%Strong, consistent evidence. Unlikely to change.
Likely70–84%Well supported, with some gaps or indirect evidence.
Uncertain50–69%Mixed or limited evidence. Genuinely open.
Doubtful30–49%Little support; the weight of evidence leans against it.
Refuted< 30%The evidence contradicts it — confidently false as stated.
Where the evidence sits in time
Long-standingMost of this evidence is older than the rest of this field.